ArticleMolecular biomedicine2025

Delta-like ligand 4 mediated myeloid-derived suppressor cell metabolic reprogramming promotes neoadjuvant therapy resistance in titin-inactivated triple-negative breast cancer.

Yanfang Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.